Alyeska Investment Group’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-120,750	Closed	-$1.69M	–	634
2022 Q1	$1.69M	Buy	120,750 +5,750	+5%	+$80.6K	0.02%	450
2021 Q4	$3.33M	Hold	115,000	–	–	0.04%	360
2021 Q3	$3.45M	Buy	+115,000	New	+$3.45M	0.04%	401